IMCD N.V. (GB:0QVU) has released an update.
IMCD N.V. has announced the acquisition of Daoqin, a prominent distributor of food and nutraceutical ingredients in China, to enhance its presence in the life science sector. This strategic acquisition, expected to close in the second quarter of 2025, aims to leverage Daoqin’s expertise to bolster IMCD’s capabilities and offerings in the Chinese market.
For further insights into GB:0QVU stock, check out TipRanks’ Stock Analysis page.